Revolution Medicines, Inc. is 23.8x more valuable than Maze Therapeutics, Inc. by market capitalization ($30.65 B vs $1.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MAZE | RVMD |
|---|---|---|
| Market cap | $1.29 B | $30.65 B |
| US-listed rank | #2448 | #454 |
| Revenue (latest FY) | $167.50M | $0.00 |
| Net income (latest FY) | -$131.12M | -$1.13B |
| Net margin | -78.3% | - |
| SEC filings | 165 | 782 |
Revolution Medicines, Inc. is 23.8x more valuable than Maze Therapeutics, Inc. by market capitalization ($30.65 B vs $1.29 B).
In their latest fiscal years, Maze Therapeutics, Inc. reported $167.50M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Maze Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.